Keywords: AEDs; antiepileptic drugs; FBTCS; focal to bilateral tonic-clonic seizure; CI; confidence interval; CS; cortical stimulation; DDD; defined daily dose; FS; focal seizure; ILAE; International League Against Epilepsy; OR; odds ratio; PI; posterior interval
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BCR; Belgian cancer registry; IMA; intermutualistic agency; NNSS; national number for social security; ICD; international classification of disease; DDD; defined daily dose; OS; overall survival; CSS; cancer specific survival; HR; hazard ratio; CI; confid
Keywords: Antimicrobial consumption; Antibiotic use; Pharmacoepidemiology; Long-term; Broad-spectrum; AMR; Antimicrobial resistance; ASP; Antimicrobial stewardship programs; DDD; Defined daily dose; DID; DDD per 1000 inhabitants per day; JPM; Japan Pharmaceutical M
Keywords: ACCORD; Action to Control Cardiovascular Risk in Diabetes; aDCSI; adapted Diabetes Complication Severity Index; AGE; advanced glycation end product; Apo; apolipoprotein; BRB; blood-retina barrier; CI; confidence interval; DDD; defined daily dose; DM; di
Keywords: Statin; Asthma exacerbation; Adulthood asthma; AHR; Adjusted hazards ratio; cDDD; Cumulative DDD; CI; Confidence interval; DDD; Defined daily dose; ED; Emergency department; LHID; Longitudinal Health Insurance Database; NHI; National Health Insurance; NHI
Keywords: Artificial disk; Degenerative disk disease; Low back pain; Lumbar arthroplasty; Lumbar fusion; Lumbar spine; Total disk replacement; ALIF; Anterior lumbar interbody fusion; ASDeg; Adjacent segment degeneration; ASDis; Adjacent segment disease; CCM; Cobalt
Keywords: ACEI; angiotensin-converting enzyme inhibitor; AKI; acute kidney injury; AKI-D; dialysis-requiring acute kidney injury; ARB; angiotensin II receptor blocker; AT; as-treated; CAD; coronary artery disease; CCIS; Charlson Comorbidity Index score; cDDD; cumul
Keywords: AUD; alcohol use disorder; ABS; proportion of participants abstinent; CBT; cognitive behavioral therapy; DDD; drinks per drinking day; PDA; percentage of days abstinent; PHD; percentage of heavy days drinking; Alcohol use disorder; Duration; Dose-effect;
Keywords: CI; confidence interval; CYP11A1; cytochrome P450 family 11 subfamily A member 1; CYP17A1; cytochrome P450 family 17 subfamily A member 1; CYP19A1; cytochrome P450 family 19 subfamily A member 1; DDD; dichlorodiphenyldichloroethane; DDE; dichlorodiphenyld
Keywords: ADD; animal daily dose; ADDD; animal defined daily dose; AMR; antimicrobial resistance; CASP; critical appraisal skills programme; DADD; defined animal daily dosage; DDD; defined daily dose; DDDA; daily doses animal; DDDvet; defined daily dose; DCDvet; de
Keywords: ACA; Affordable Care Act; DD; Difference-in-Differences; DDD; Difference-in-Difference-in-Differences; ESHI; Employer-Sponsored Health Insurance; SIPP; Survey of Income Program and Participation; H51; I18; D14; Health insurance; Financial portfolio; Healt
Keywords: Acid-Related Diseases; Side-Effects; Treatment; Epidemiology; CI; confidence interval; DDD; defined daily dose; H2RA; histamine-2 receptor antagonists; LSADT; Longitudinal Study of Aging Danish Twins; MADT; Middle-Aged Danish Twin study; PPI; proton pump
Keywords: Schizophrenia; Antipsychotics; Community pharmacy services; Pharmaceutical services; Medication adherence; Continuity of patient care; RAMQ; Régie de l'assurance-maladie du Québec; GIS; guaranteed income supplement; ICD; International Classification of
Keywords: CCETP; Enterprise innovation; DID; DDD; C31; Q56; Q58;
Keywords: Schizophrenia; Parkinson's disease; Antipsychotic drugs; Axial parkinsonian signs; APs; antipsychotic drugs; DDD; defined daily dose; DIP; Drug-induced parkinsonism; DRBA; dopamine receptor blocking agents; 123I-FP-CIT SPECT; single photon emission comput
Keywords: mortality; National Inpatient Sample; pacemakers; tamponade; DDD; dual-chamber; ICD-9-CM; International Classification of Diseases-Ninth Revision-Clinical Modification; NIS; National (Nationwide) Inpatient Sample; PPM; permanent pacemaker;
Keywords: Polycystic ovary syndrome; Organochlorine pesticides; Endocrine disrupting; Serum; BMI; body mass index; CVD; cardiovascular disease; DBP; diastolic blood pressure; DCM; dichloromethane; DDD; dichlorodiphenyldichloroethane; DDE; dichlorodiphenyldichloroet
Keywords: AOM; acute otitis media; ATC; anatomical therapeutic chemical classification system; CI; confidence interval; DDD; defined daily dose; DNHR; Danish national health register; IPD; invasive pneumococcal disease; NCSP; NOMESCO classification of surgical proc
Keywords: aHR; adjusted hazard ratio; DDD; defined daily dose; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; IQR; interquartile range; LHID2000; Longitudinal Health Insurance Database 2000; NHI; Nationa
Keywords: AAI; single-chamber atrial pacing; CAEs; cardiovascular adverse events; CI; confidence interval; DDD; dual-chamber pacing; DRCs; device-related complications; HR; hazard ratio; SD; standard deviation; VVI; single-chamber ventricular pacing;
Keywords: Lumbar degenerative disk disease; Objective functional impairment; Patient-reported outcome measures; Smoking; Subjective functional impairment; Timed Up and Go test; BMI; Body mass index; CI; Confidence interval; DDD; Degenerative disk disease; EQ-5D; Eu
Keywords: 5-HT; serotonin; AOR; adjusted odds ratio; CI; confidence interval; DDD; defined daily dose; ICD-9-CM; International Classification of Diseases, 9th Revision, Clinical Modification; IOP; intraocular pressure; kD; dissociation constant; NHI; National Healt
Keywords: ACS; Acute coronary syndrome; AP; Angina pectoris; ASA; Acetylsalicylic acid; ATC; Anatomical-therapeutical-chemical classification; BMS; Bare metal stent; CAD; Coronary artery disease; DAPT; Dual antiplatelet therapy; DDD; Defined daily dose; DES; Drug e
Keywords: avascular necrosis; comorbidities; inflammation; National Health Insurance Research Database; osteonecrosis; psoriasis; aHR; adjusted hazard ratio; AVN; avascular necrosis; CI; confidence interval; DDD; defined daily doses; HR; hazard ratio; ICD-9-CM; Int
Keywords: ACAT; Aged Care Assessment Team; ADE; adverse drug event; BZD; benzodiazepine; DAA; dose administration aid; DDD; defined daily dose; GP; general medical practitioner; HYVET; Hypertension in the Very Elderly Trial; MAC; Medication Advisory Committee; PART
Keywords: PHC; primary health care; CPG; Clinical Practice Guidelines; RCTs; randomized clinical trials; EHR; electronic health records; SIDIAP-Q; Information System for the Development of Research in Primary Care- Quality; BP; blood pressure; HbA1c; glycated haemo
Keywords: CCD; charged coupled device; CDF; cumulative distribution function; CTF; contrast transfer function; Cryo-EM,; cryogenic electron microscopy; Cryo-TEM,; cryogenic transmission electron microscopy; DDD; direct (electron) detection device; DQE; detector qua
Keywords: DDD; drug delivery device; DDR; diffusion-driven drug release; HDR; hydrodynamically-driven drug release; HFHP; hollow fiber of high hydrodynamic permeability; MIC; minimum inhibition concentration; MW; molecular weight; LB; lymphatic bed; LN; lymph node;
Keywords: Acid Suppression; Cognitive Dysfunction; Gut Microbiota; Liver Failure; cDDD; cumulative defined daily dose; CI; confidence interval; DDD; defined daily dose; GI; gastrointestinal; HE; hepatic encephalopathy; ICD-9-CM; International Classification of Dise
Keywords: Helicobacter pylori Screening; Randomized Controlled Trial; Dyspepsia; Peptic Ulcer Disease; ASA; acetylsalicylic acid; CCI; Charlson Comorbidity Index; CI; confidence interval; DDD; defined daily dose; GERD; gastroesophageal reflux disease; GP; general p
Keywords: Fusion; Intervertebral disc; Lumbar; Spine; Surgery; Vertebrae; ALIF; Anterior lumbar interbody fusion; DDD; Degenerative disc disease; MCS; Mental Component Summary; ODI; Oswestry Disability Index; PCS; Physical Component Summary; PLIF; Posterior lumbar
Keywords: ATC; anatomic therapeutic chemical; ARPA; Regional Agency for Environmental Protection; CI; confidence interval; DDD; defined daily dose; IS; internal standard; LABAs; long-acting beta-agonists; PM2.5; particulate matter with aerodynamic diameter â¤2.5Â
Keywords: AED; antiepileptic drug; DDD; defined daily dose; ESS; Epworth Sleepiness Scale; GAD-7; Generalized Anxiety Disorder - 7; HPA; hypothalamic-pituitary-adrenal; ISI; Insomnia Severity Index; K-NDDI-E; Korean version of the Neurological Disorders Depre
Keywords: C3GN; C3 glomerulonephritis; CFH; complement factor H; DDD; dense-deposit disease; MPGN; membranoproliferative glomerulonephritis;
Keywords: AB; Antibiotic; API; active pharmaceutical ingredient; DDD; defined daily dose; PHC; personalised healthcare; MAb; monoclonal antibody; PIE; pharmaceuticals in the environment; WWTP; wastewater treatment plant; Active pharmaceutical ingredients; Environme
Keywords: Antibiotics; antimicrobial stewardship; prescribing; dentists; AAOS; American Academy of Orthopaedic Surgeons; ADA; American Dental Association; BC; British Columbia; DDD; Defined daily dose; DID; Defined daily doses per 1,000 inhabitants per day;
Keywords: DDD; defined daily dose; DTI; direct thrombin inhibitor; ELISA; enzyme-linked immunosorbent assay; HIT; heparin induced thrombocytopenia; HITT; heparin induced thrombocytopenia with thrombosis; SRA; serotonin release assay; T≻ test and switch, continue
Keywords: Cervical disc arthroplasty (CDA); Increased intramedullary signal intensity (IISI); Myelopathy; ACDF; Anterior cervical discectomy and fusion; CDA; Cervical disc arthroplasty; CSM; Cervical spondylotic myelopathy; DDD; Degenerative disc disease; FDA; U.S.
Keywords: EL; electroless; TMB-HCL; 3,3â²,5,5â²-tetramethylbenzidine dihydrochloride; NBS; N-bromosuccinimide; TFA; trifluoroacetic acid; ICP-OES; inductively coupled plasma optical emission spectrometry; SERS; surface enhanced Raman spectroscopy; LOQ; lower limi
Keywords: Expo 67; Saint Lawrence River; Sediment contamination; DDD; History; Paleolimnology;
Keywords: AChE; Acetylcholinesterase; BChE; Butyrylcholinesterase; DDT; Dichlorodiphenyltrichloroethane; DDE; Dichlorodiphenylethane; DDD; Dichlorodiphenyldichloroethane; EBDC; Ethylene-bis-dithiocarbamate; FT4; Free thyroxine; HCH; Hexachlorocyclohexane; HCB; Hexa
Keywords: CI; confidence interval; CRC; colorectal cancer; DDD; daily defined dose; HR; hazard ratio; Hydroxymethylglutaryl-CoA reductase inhibitors; Colorectal neoplasms; Survival; Pharmacoepidemiology; Review; Systematic; Meta-analysis;
Keywords: HMG-CoA; Pleiotropy; Esophagus; CPRD; BMI; body mass index; CI; confidence interval; DDD; defined-daily dose; EAC; esophageal adenocarcinoma; EC; esophageal cancer; EGJA; esophagogastric junctional adenocarcinoma; ESCC; esophageal squamous cell carcinoma;
Keywords: AD; Alzheimer disease; DDD; defined daily dose; PRE2DUP; prescription to drug use period; SII; Social Insurance Institution of Finland;
Keywords: Crohn's Disease; Birth Control; Surgery; Swedish National Patient Register; CI; confidence interval; DDD; defined daily dose; HR; hazard ratio; MV; multivariable; OC; oral contraceptive;
Keywords: Back pain; Degenerative disc disease; Dominant symptom; Health-related quality of life; Leg pain; Low back pain; Lumbar spine surgery; BMI; Body mass index; CI; Confidence interval; COMI; Core Outcome Measures Index; D3; 3 days; DDD; Degenerative disc dis
Keywords: AED; anti-epileptic drug; BMI; body mass index; CBZ; carbamazepine; CLB; clobazam; CLZ; clonazepam; CWO; control children; CWE; children of women with epilepsy; DDD; daily defined dose; FSIQ; Full Scale IQ; KREP; Kerala Registry of Epilepsy and Pregnancy;
Keywords: CI; confidence interval; CRP; C-reactive protein; CVE; cerebrovascular event; DDD; daily defined dose per 100 hospital bed days; ECMO; extracorporeal membrane oxygenator support; IQR; interquartile range; SD; standard deviation; SIRS; systemic inflammator
Keywords: Antibiotic stewardship; Restrictive reporting; DDD; Defined daily doses; Antimicrobial resistance
Keywords: Chronic kidney disease; Drugs; Phosphate; Observational study; Cardiovascular risk; 1,25-OH-D; 1,25 dihydroxy vitamin D; API; active pharmaceutical ingredient; ATC; anatomic therapeutic class; ATP; adenosine triphosphate; CKD; chronic kidney disease; DDD;